Related references
Note: Only part of the references are listed.Mechanisms of cancer cell killing by metformin: a review on different cell death pathways
Xiao-yu Wu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2023)
Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer
Jida Chen et al.
FEBS OPEN BIO (2022)
Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma
Wei-Ming Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
Chuanfen Zhang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2022)
The Role of EREG/EGFR Pathway in Tumor Progression
Wan-Li Cheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
Shiqi Ma et al.
ONCOGENE (2021)
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
Jiawen Yang et al.
CELL DEATH & DISEASE (2021)
Metformin Increases Survival in Hypopharyngeal Cancer Patients with Diabetes Mellitus: Retrospective Cohort Study and Cell-Based Analysis
Yung-An Tsou et al.
PHARMACEUTICALS (2021)
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
G. Emerens Wensink et al.
NPJ PRECISION ONCOLOGY (2021)
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
Jingjing Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
Mickael Burgy et al.
CANCERS (2021)
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
Ze Zhang et al.
BRITISH JOURNAL OF CANCER (2020)
The impact of diabetes in head and neck cancer
Isabel Vilaseca et al.
CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
Novel insights into ferroptosis: Implications for age-related diseases
Ren-Peng Zhou et al.
THERANOSTICS (2020)
EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
Shuli Liu et al.
THERANOSTICS (2020)
The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
Mengjia He et al.
ONCOGENE (2019)
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy
Else Driehuis et al.
CANCER DISCOVERY (2019)
Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway
Yujia Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction
Sylvie Job et al.
CANCERS (2019)
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
Michaela Poliakova et al.
MOLECULAR CANCER (2018)
Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma
Amie Ogunsakin et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab
Yasunao Kogashiwa et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity
Noriaki Tanaka et al.
ORAL ONCOLOGY (2018)
Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy
Joanne Sloan-Lancaster et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis
Xiaoan Tao et al.
CANCER LETTERS (2017)
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics
Daniel M. Freed et al.
CELL (2017)
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Jong-Lyel Roh et al.
CANCER LETTERS (2016)
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
Haiquan Lu et al.
CANCER LETTERS (2016)
Organoids as an in vitro model of human development and disease
Aliya Fatehullah et al.
NATURE CELL BIOLOGY (2016)
Diabetes mellitus, metformin and head and neck cancer
Rejane Augusta de Oliveira Figueiredo et al.
ORAL ONCOLOGY (2016)
Ferrootosis: Death by Lipid Peroxidation
Wan Seok Yang et al.
TRENDS IN CELL BIOLOGY (2016)
Amino Acid Transporters in Cancer and Their Relevance to Glutamine Addiction: Novel Targets for the Design of a New Class of Anticancer Drugs
Yangzom D. Bhutia et al.
CANCER RESEARCH (2015)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells
C. Oliveras-Ferraros et al.
BRITISH JOURNAL OF CANCER (2012)
Caveolin-1 Overexpression Is Associated With Simultaneous Abnormal Expression of the E-cadherin/α-β Catenins Complex and Multiple ErbB Receptors and With Lymph Nodes Metastasis in Head and Neck Squamous Cell Carcinomas
Laura Masuelli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Toni M. Brand et al.
CANCER BIOLOGY & THERAPY (2011)
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Toshiro Sato et al.
NATURE (2009)
Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt
Kai Hu et al.
ORAL ONCOLOGY (2009)
Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor
Kirstine Roepstorff et al.
TRAFFIC (2009)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
U Sahin et al.
JOURNAL OF CELL BIOLOGY (2004)
Share Paper
